Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
AM Hoffmann-Vold, Y Allanore, M Alves… - Annals of the …, 2021 - ard.bmj.com
Objectives To identify overall disease course, progression patterns and risk factors
predictive for progressive interstitial lung disease (ILD) in patients with systemic sclerosis …
predictive for progressive interstitial lung disease (ILD) in patients with systemic sclerosis …
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
ER Volkmann, DP Tashkin, M Sim, N Li… - Annals of the …, 2019 - ard.bmj.com
Objective To assess survival and identify predictors of survival in patients with systemic
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
W Wu, S Jordan, MO Becker, R Dobrota… - Annals of the …, 2018 - ard.bmj.com
Objectives To identify the predictive clinical characteristics and establish a prediction model
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …
[HTML][HTML] Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
S Adler, D Huscher, E Siegert, Y Allanore… - Arthritis research & …, 2018 - Springer
Background Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …
Treatment for systemic sclerosis-associated interstitial lung disease
Treatment for systemic sclerosis-associated interstitial lun... : Current Opinion in
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …
Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis
NS Goh, RK Hoyles, CP Denton… - Arthritis & …, 2017 - Wiley Online Library
Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group
Objective Patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD) are
thought to have the greatest decline in lung function (forced vital capacity [FVC]% predicted) …
thought to have the greatest decline in lung function (forced vital capacity [FVC]% predicted) …
[PDF][PDF] Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease
Objective. Clinically meaningful change in systemic sclerosis (SSc) related interstitial lung
(SSc-ILD) disease is unknown. The aim of this study was to quantify change in pulmonary …
(SSc-ILD) disease is unknown. The aim of this study was to quantify change in pulmonary …
Predictive value of serial high‐resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis
AM Hoffmann‐Vold, TM Aaløkken… - Arthritis & …, 2015 - Wiley Online Library
Objective Systemic sclerosis (SSc) carries a high risk of progressive interstitial lung disease
(ILD), but tools for stratifying individual risk are scarce. The purpose of this study was to …
(ILD), but tools for stratifying individual risk are scarce. The purpose of this study was to …
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
D Sánchez-Cano, N Ortego-Centeno… - Rheumatology …, 2018 - Springer
Objectives To evaluate the clinical characteristics of patients with interstitial lung disease
(ILD) in the setting of a large cohort of systemic sclerosis (SSc) patients, and to analyse the …
(ILD) in the setting of a large cohort of systemic sclerosis (SSc) patients, and to analyse the …
相关搜索
- systemic sclerosis lung disease
- eustar database lung disease
- patients with scleroderma lung disease
- systemic sclerosis eustar group
- eustar group lung function
- systemic sclerosis function trends
- systemic sclerosis tomography analyses
- systemic sclerosis prediction of progression
- systemic sclerosis trial cohorts
- function trends lung disease
- trial cohorts lung disease
- prediction of progression lung disease
- clinical course lung disease
- systemic sclerosis immunosuppressive therapy
- immunosuppressive therapy lung disease
- prognostic marker lung disease